511 related articles for article (PubMed ID: 10561095)
21. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
Schellhaas E; König C; Frank-Raue K; Buhr HJ; Hotz HG
Surgery; 2009 Nov; 146(5):906-12. PubMed ID: 19744457
[TBL] [Abstract][Full Text] [Related]
23. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).
Niederle B; Sebag F; Brauckhoff M
Langenbecks Arch Surg; 2014 Feb; 399(2):185-97. PubMed ID: 24297502
[TBL] [Abstract][Full Text] [Related]
24. [Early therapeutic management of patients genetically predisposed to medullary thyroid cancer].
Murat A; Modigliani E; Conte-Devolx B; Rohmer V; Leclerc L; Guilhem I; Bigorgne JC; Boneu A; Maes B; Chabre O; Niccoli P; Schuffenecker I; Giraud S
Ann Chir; 1998; 52(5):455-60. PubMed ID: 9752487
[TBL] [Abstract][Full Text] [Related]
25. [Surgical management of medullary thyroid carcinoma. Personal experience].
Geraci G; Pisello F; Tornambè A; Platia L; Sciumè C; Li Volsi F; Cupido F; Modica G
G Chir; 2007 Oct; 28(10):385-9. PubMed ID: 17915054
[TBL] [Abstract][Full Text] [Related]
26. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.
Weber T; Schilling T; Frank-Raue K; Colombo-Benkmann M; Hinz U; Ziegler R; Klar E
Surgery; 2001 Dec; 130(6):1044-9. PubMed ID: 11742336
[TBL] [Abstract][Full Text] [Related]
27. Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma?
Chandeze MM; Noullet S; Faron M; Trésallet C; Godiris-Petit G; Tissier F; Buffet C; Leenhardt L; Chereau N; Menegaux F
Ann Surg Oncol; 2016 Oct; 23(11):3653-3659. PubMed ID: 27271930
[TBL] [Abstract][Full Text] [Related]
28. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
29. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
[TBL] [Abstract][Full Text] [Related]
30. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
31. Improved results of cervical reoperation for medullary thyroid carcinoma.
Moley JF; Dilley WG; DeBenedetti MK
Ann Surg; 1997 Jun; 225(6):734-40; discussion 740-3. PubMed ID: 9230814
[TBL] [Abstract][Full Text] [Related]
32. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.
Kim MK; Mandel SH; Baloch Z; Livolsi VA; Langer JE; Didonato L; Fish S; Weber RS
Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1214-6. PubMed ID: 15492172
[TBL] [Abstract][Full Text] [Related]
33. Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution.
Ito Y; Miyauchi A; Yabuta T; Fukushima M; Inoue H; Tomoda C; Uruno T; Kihara M; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F
World J Surg; 2009 Jan; 33(1):58-66. PubMed ID: 19005720
[TBL] [Abstract][Full Text] [Related]
34. Single center experience in primary surgery for medullary thyroid carcinoma.
Ukkat J; Gimm O; Brauckhoff M; Bilkenroth U; Dralle H
World J Surg; 2004 Dec; 28(12):1271-4. PubMed ID: 15517488
[TBL] [Abstract][Full Text] [Related]
35. Extent of Surgery for Medullary Thyroid Cancer and Prevalence of Occult Contralateral Foci.
Mao YV; Hughes EG; Steinmetz D; Troob S; Kim J; Tseng CH; Fishbein GA; Sajed DP; Livhits MJ; Yeh MW; Lee D; Angell TE; Wu JX
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):209-214. PubMed ID: 38270925
[TBL] [Abstract][Full Text] [Related]
36. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A; Lorenz K; Weber F; Dralle H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
[TBL] [Abstract][Full Text] [Related]
37. Pattern of nodal metastasis for primary and reoperative thyroid cancer.
Machens A; Hinze R; Thomusch O; Dralle H
World J Surg; 2002 Jan; 26(1):22-8. PubMed ID: 11898029
[TBL] [Abstract][Full Text] [Related]
38. Approach to lymph node metastases in sporadic medullary thyroid carcinoma An istitutional experience.
Polistena A; Monacelli M; Lucchini R; Triola R; Conti C; Avenia S; Barillaro I; Sanguinetti A; Avenia N
Ann Ital Chir; 2015; 86():390-5. PubMed ID: 26567553
[TBL] [Abstract][Full Text] [Related]
39. Reoperation for recurrent or persistent medullary thyroid cancer.
Moley JF; Wells SA; Dilley WG; Tisell LE
Surgery; 1993 Dec; 114(6):1090-5; discussion 1095-6. PubMed ID: 8256212
[TBL] [Abstract][Full Text] [Related]
40. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]